A study quantitatively analyzed the levels of anti-PEG IgG, IgM, and IgE antibodies in blood samples from a clinical trial involving administration of Comirnaty®, a COVID-19 vaccine based on PEGylated lipid nanoparticles [27]. This evidence concerns the gene IGHE and COVID-19.